TCL Archive Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities April 28, 1995
TCL Archive Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds October 31, 2003
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
